Report cover image

Global Invasive Neuromodulation Market Growth (Status and Outlook) 2025-2031

Published Jun 12, 2025
Length 140 Pages
SKU # LPI20084698

Description

The global Invasive Neuromodulation market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Neuromodulation is a medical device that regulates and stimulates the activity of the nervous system. It is designed to provide a therapeutic effect by delivering electrical or chemical stimulation to specific areas of the body or to specific nerves. Neuromodulation devices are commonly used to treat a variety of neurological disorders and chronic pain that do not respond to traditional therapies.

The specific application and function of neuromodulation depends on the disease being treated and the target area of the nervous system. These devices are usually prescribed and implanted by medical professionals trained in neuromodulation therapy.

United States market for Invasive Neuromodulation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Invasive Neuromodulation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Invasive Neuromodulation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Invasive Neuromodulation players cover Medtronic, Boston Scientific Corporation, Abbott, LivaNova, Cerbomed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Invasive Neuromodulation Industry Forecast” looks at past sales and reviews total world Invasive Neuromodulation sales in 2024, providing a comprehensive analysis by region and market sector of projected Invasive Neuromodulation sales for 2025 through 2031. With Invasive Neuromodulation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Invasive Neuromodulation industry.

This Insight Report provides a comprehensive analysis of the global Invasive Neuromodulation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Invasive Neuromodulation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Invasive Neuromodulation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Invasive Neuromodulation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Invasive Neuromodulation.

This report presents a comprehensive overview, market shares, and growth opportunities of Invasive Neuromodulation market by product type, application, key players and key regions and countries.

Segmentation by Type:
Deep Brain Stimulator
Vagus Nerve Stimulator
Spinal Cord Stimulator
Others

Segmentation by Application:
Parkinson's Disease
Epilepsy
Migraine
Depression
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific Corporation
Abbott
LivaNova
Cerbomed
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Nevro
Beijing Pins Medical
SceneRay
RISHENA
Znion HK

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

140 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Invasive Neuromodulation Market Size by Player
4 Invasive Neuromodulation by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Invasive Neuromodulation Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.